| H. SROUSSI 1, M. CHENG1, D. HANNA2, L. KASTE1
1UIC College of Dentistry, Chicago, IL, 2Nova Southeastern University
College of Dental Medicine, Fort Lauderdale, FL, USA
Objectives: HIV-positive dental patients are at high risk
for oral hard (HTL) and soft tissue lesions (STL). Little has been published
on connections between HTL and STL. The purpose of this study is to assess
the association between HTL and STL in adult HIV-positive dental patients.
Methods: A retrospective chart audit of HTL was performed
of patients of the former UIC College of Dentistry Ryan White Dental Clinic.
STL data from a previous study were merged with the HTL data and the
combined data set was analyzed using SPSS.
Results: The study population (n=71), with a mean age in
years of 44.7(SD+8.8), was predominantly black (52.9%), homosexual (53.6%),
male (80.3%), poor (annual income less than $5,000, 53.9%), limited in
health insurance (none 43.9% and Medicaid 29.8%) and smoked (50.7%). Immune
status measurements were taken an average 105(+67) months since
seroconversion and demonstrated a mean CD4 count of 372(+196), and mean
viral load of 14,695(+29,879). The mean HTL assessments were sound teeth
(ST) =12.5(+7.9), DT=7.4(+5.3), FT=3.1(+3.5), MT=8.3(+6.1), DFT=10.5(+5.5),
and DMFT=18.8(+7.7). The STL data showed 52.1% had an abnormal soft tissue
exam: 36.6% had oral candidiasis, 9.9% had hairy leukoplakia, and 5.6% had
oral warts. Important bivariate contrasts of HTL means included: abnormal or
normal STL exam and DFT (9.3 and 11.8, p=.06); oral candidiasis or not and
MT (10.2 and 7.2, p=.048); oral warts or not and FT (0.3 and 3.3, p=.09);
and hairy leukoplakia or not and ST (20.4 vs. 11.6, p=.004), DT (3.9 vs.
7.8, p=.06), DFT (5.1 vs. 11.1, p=.006), and DMFT (10.4 vs. 19.8, p=.002).
Conclusion: The expected association of having STL and
elevated measures of HTL did not occur except between oral candidiasis and
missing teeth. Further analysis of these data and additional studies are
necessary to verify the findings and explore the plausibility of oral
lesions for immune surveillance of HIV+ individuals. |